ABT inks deal with JNJ/PCYC for ibrutinib companion diagnostic: http://finance.yahoo.com/news/abbott-collaborate-janssen-pharmacyclics-development-140000515.html The financial terms were not disclosed. ABT inked a similar deal with PFE for the companion diagnostic to Xalkori (#msg-66584680).